Implantable system for the diagnostic and/or therapeutic treatment of a human patient or an animal patient

A treatment system, comprising:

• an implantable system for a diagnostic and/or therapeutic treatment of a heart of a patient including a human patient or an animal patient, said implantable system containing a first processor, a first memory, a treatment unit and a first remote data transmitter;
• a remote access unit disposed remotely from said implantable system, said remote access unit containing a second processor, a second memory and a second remote data transmitter;
• said first memory storing a first computer-readable program, which prompts said first processor to carry out the following steps when the first computer-readable program is being executed on said first processor:
• delivering, by said treatment unit, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of said treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
• receiving reactivation data by way of the first remote data transmitter;
• and
• reactivating the ability of said treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received;
• and
• said second memory unit storing a second computer-readable program, which prompts said second processor to carry out the following steps when the second computer-readable program is being executed on said second processor:
• generating the reactivation data in response to an input or a program request;
• and
• transmitting the reactivation data by way of the second remote data transmitter.

A method for controlling an operation of an implantable system for a diagnostic and/or therapeutic treatment of a heart of a patient including a human patient or an animal patient, which comprises the following steps of:

• delivering, by a treatment unit of the implantable system, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
• receiving reactivation data by way of a remote data transmission unit;
• and
• reactivating the ability of the treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received.

A non-transitory computer medium storing a computer program product having computer-readable code, which prompts a processor to carry out the following steps when the computer-readable code is being executed on the processor:

• delivering, by a treatment unit of an implanted system, atrial antitachycardia stimulation to a heart of a patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, wherein the implanted system is configured at least for a therapeutic treatment of a heart of a patient, including a human patient or an animal patient, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
• receiving reactivation data by way of a remote data transmission unit;
• and
• reactivating the ability of the treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received.

A method for treating a patient including a human patient or an animal patient requiring treatment, by way of an implantable system which performs a diagnostic and/or therapeutic treatment of the human patient or the animal patient, the implantable system containing a processor, a memory, a treatment unit and a remote data transmitter, the method comprises the following steps of:

• delivering, by the treatment unit of the implantable system, atrial antitachycardia stimulation to the heart of the patient and then reducing a risk of thrombosis by deactivating an ability of the treatment unit to deliver further atrial antitachycardia stimulation after an expiration of a presettable time, the presettable time being a time period of about 48 hours and after which an unsuccessful treatment of atrial tachycardia increases the patient's risk of thrombosis;
• receiving reactivation data by way of the remote data transmitter;
• reactivating the ability of the treatment unit to subsequently deliver the further atrial antitachycardia stimulation based on the reactivation data that was received;
• and
• delivering, by the treatment unit, the further atrial antitachycardia stimulation to the patient.